06/02/2026
MKPPL is proud to announce the successful completion of an EU Audit at both of our manufacturing facilities. The comprehensive 5-day audit covered our PFI division, Oral Solid Dosage division, Oral Liquids, Transdermal Products, and External Preparations. This is our unwavering commitment to quality, compliance, and global regulatory standards. It is a testament to the dedication, expertise, and teamwork of our entire organization, who consistently strive for excellence in every process.
Meeting stringent EU requirements strengthens our position as a trusted pharmaceutical partner and reinforces our focus on delivering safe, high-quality products worldwide.
We move forward with renewed confidence, credibility, and a strong foundation for global growth.
Visit us for more information: www.murlikrishnapharma.com
-----------